ACI-24.060
Phase 2- Indications
- Alzheimer's disease
Company intelligence / Profile preview
ACI Pharmaceuticals is one of the leading pharmaceutical companies in Bangladesh with a commercial-stage portfolio. It manufactures and markets more than 550 SKUs covering over 250 molecules across nearly 100 therapeutic classes. The company has introduced advanced manufacturing technologies including biosimilars, insulin, bi-layer tablets, lyophilized products, hormone preparations, ophthalmic drugs, novel drug delivery systems and more. It also acts as a contract manufacturer for multinational companies such as Servier and distributes vaccines from Sanofi.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ACI Pharmaceuticals.